ThePeptideGuide.uk LogoNavigation

Educational purposes only. Not medical advice. Consult healthcare professionals before use.

Healing & Recovery
Phase 2

BPC-157 (Immune)

BPC-157 (Immune)

Also known as: BPC, Bepecin, PL 14736

Overview

Key Facts

Primary Goal: A pentadecapeptide derived from human gastric juice, primarily known for tissue healing but increasingly recognized for its immunomodulatory properties

A pentadecapeptide derived from human gastric juice, primarily known for tissue healing but increasingly recognized for its immunomodulatory properties. Modulates immune responses, protects against immune-mediated gut damage, and supports mucosal immunity. Half-Life 4 hours (estimated) Typical Dose 250–500 mcg Frequency 1-2x daily Cycle Length 4-12 weeks

Dosing Information

Half-Life

4 hours (estimated)

Typical Dose

250–500 mcg

Frequency

1-2x daily

Cycle Length

4-12 weeks

Administration Routes:

subcutaneousintramuscularoral

Storage & Reconstitution

Unreconstituted (Powder)

Temperature2–8°C (36–46°F) or -20°C (-4°F) for long-term
DurationUp to 3 months

Reconstituted (Mixed)

Temperature2–8°C (36–46°F)
Duration2-4 weeks

Research Summary

Phase 2
100 studies

Over 100 published studies on BPC-157, many demonstrating immune-relevant effects including cytoprotection, anti-inflammatory activity, and mucosal immune barrier preservation. Phase 2 trials conducted for inflammatory bowel disease. Immune modulation is considered a key secondary mechanism underlying its healing properties. Cross-reference: see bpc-157 in healing-recovery for full tissue repair profile.

Frequently Asked Questions

Common questions about BPC-157 (Immune)

UK-Specific Information

Exclusive data points and guidance for UK residents using BPC-157 (Immune)

UK Lab Testing

US Lab Testing

Recommended labs: Quest Diagnostics, LabCorp ($120-$200 for peptide safety panel)

Why this matters: UK-specific lab testing guidance not available on US competitor sites

Commonly Stacked With